Skip to main content
Claudia Chiriboga, MD, Child Neurology, New York, NY, NewYork-Presbyterian/Columbia University Irving Medical Center

ClaudiaA.ChiribogaMD

Child Neurology • New York, NY

MD, MPH Columbia Presbyterian Medical Center

Request Appointment

Overview of Dr. Chiriboga

Dr. Claudia Chiriboga is a Child Neurologist in New York, NY and is affiliated with multiple hospitals in the area, including NewYork-Presbyterian/Columbia University Irving Medical Center and Morgan Stanley Childrens Hospital of NewYork-Presbyterian. She received her medical degree from University of Buenos Aires and has been in practice 38 years. She is one of 23 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 10 doctors at Morgan Stanley Childrens Hospital of NewYork-Presbyterian who specialize in Child Neurology. She has more than 50 publications and over 500 citings.

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Pediatrics, 1982 - 1985
  • University of Buenos Aires
    University of Buenos AiresClass of 1982

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License Current
  • NY State Medical License
    NY State Medical License 1985 - 2024
  • MD State Medical License
    MD State Medical License 1984 - 1986
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Publications & Presentations

PubMed

Press Mentions

  • Positive New Data for Genentech’s Evrysdi in Largest Trial Ever Undertaken in Patients with Previously-Treated Spinal Muscular Atrophy (SMA)
    Positive New Data for Genentech’s Evrysdi in Largest Trial Ever Undertaken in Patients with Previously-Treated Spinal Muscular Atrophy (SMA)October 12th, 2022
  • New Genentech Data for Evrysdi (Risdiplam) Show Improved Motor Function in Pre-Symptomatic Babies After One Year and Confirm Safety Profile in Previously Treated People with Spinal Muscular Atrophy (SMA)
    New Genentech Data for Evrysdi (Risdiplam) Show Improved Motor Function in Pre-Symptomatic Babies After One Year and Confirm Safety Profile in Previously Treated People with Spinal Muscular Atrophy (SMA)June 11th, 2021

Hospital Affiliations

Dr. Claudia Chiriboga, Dr. Claudia Chiriboga, MD, Dr. C Chiriboga, Dr. Claudia A. Chiriboga